P/E at 65.9 vs Industry's 67.2: What the Data Shows for Max Healthcare Institute Ltd

1 hour ago

Share Via

A price-to-earnings ratio of 65.89 against an industry average of 67.22. That's a slight discount to the hospital sector's valuation. Max Healthcare Institute Ltd, previously rated Sell by MarketsMojo, has had its rating reassessed. The one-year return of -17.92% notably underperforms the Sensex's -5.52%, while the year-to-date loss of -3.29% is less severe than the broader market's -9.49%. The data reveals a complex performance picture across timeframes.

Valuation Picture: Slight Discount in a High-Valuation Sector

The hospital industry currently trades at a P/E of 67.22, reflecting elevated valuations driven by growth expectations and sector resilience. Max Healthcare Institute Ltd trades at a P/E of 65.89, marginally below the sector average. This 2.0% discount suggests the market is pricing in slightly lower growth or higher risk relative to peers. Given the stock's mid-cap status with a market capitalisation of ₹98,354.46 crores, this valuation positioning is noteworthy. The premium or discount relative to sector peers often signals investor sentiment about earnings sustainability and growth prospects — previously rated Sell, what is Max Healthcare's current rating?

Performance Across Timeframes: Divergent Momentum

Examining returns reveals a divergence between short- and long-term momentum. Over the past year, Max Healthcare Institute Ltd has declined by 17.92%, significantly underperforming the Sensex's 5.52% loss. The three-month return of -5.27% contrasts with the Sensex's positive 2.57%, indicating recent weakness. However, the year-to-date performance of -3.29% is better than the Sensex's -9.49%, suggesting some recovery in the first half of 2026. The stock's one-month return of -7.26% also underperforms the Sensex's -1.30%, highlighting short-term pressure. This mixed performance raises the question — is this a temporary setback or a sign of deeper challenges?

Moving Average Configuration: Signs of a Partial Recovery Amid Larger Downtrend

The technical picture for Max Healthcare Institute Ltd shows the stock trading above its 5-day moving average but below the 20-day, 50-day, 100-day, and 200-day moving averages. This configuration typically indicates a short-term bounce within a longer-term downtrend. The recent two-day gain of 1.22% supports this interpretation, but the inability to break above longer-term averages suggests resistance remains strong. The stock opened at ₹1,016 and has traded near this level, reflecting consolidation. The 5-day average support may provide a base, but the broader trend remains under pressure — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Relative Performance: Outperformance Over Longer Horizons

While recent returns have been disappointing, Max Healthcare Institute Ltd has delivered strong gains over longer periods. The three-year return stands at 89.44%, substantially outperforming the Sensex's 18.76%. Over five years, the stock has surged 194.62%, compared to the Sensex's 38.66%. This long-term outperformance highlights the company's ability to generate shareholder value despite short-term volatility. The absence of a 10-year return figure suggests a more recent listing or restructuring, but the available data confirms a robust medium-term track record. This contrast between short-term weakness and long-term strength invites the question — should investors in Max Healthcare hold, buy more, or reconsider?

Sector Context: Mixed Results in the Hospital Industry

The hospital sector has experienced a varied performance landscape recently. While the industry P/E remains elevated at 67.22, reflecting optimism about healthcare demand and innovation, sector returns have been uneven. Some companies have posted gains, while others face margin pressures and regulatory challenges. Max Healthcare Institute Ltd's underperformance relative to the Sensex and its peers may reflect company-specific factors or broader sector headwinds. The stock's mid-cap status places it in a competitive position, but the sector's mixed results underscore the importance of analysing individual fundamentals and technicals carefully.

Rating Context: Previously Rated Sell, Now Reassessed

MarketsMOJO had previously assigned a Sell rating to Max Healthcare Institute Ltd. On 24 July 2026, the rating was updated, reflecting changes in the company's performance and valuation metrics. The current Mojo Score stands at 50.0, with a Hold grade assigned. This reassessment aligns with the data showing a valuation close to the sector average and mixed performance signals. The rating update invites investors to reanalyse the stock's prospects in light of recent trends — what is the current rating?

Conclusion: A Complex Data Story Demands Careful Analysis

The data on Max Healthcare Institute Ltd paints a nuanced picture. Its P/E ratio is slightly below the hospital sector average, suggesting a modest valuation discount. Performance across timeframes is mixed, with recent underperformance contrasting with strong medium-term gains. The moving average configuration indicates a short-term bounce within a longer-term downtrend, while the sector's mixed results add further complexity. The rating update from Sell to Hold reflects these dynamics. Collectively, the data invites investors to weigh valuation, momentum, and technical signals carefully — should investors in Max Healthcare hold, buy more, or reconsider?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)

MOJO SCORE